These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10468395)

  • 1. Policy analysis for end-stage renal disease in Jamaica.
    Trisolini M; Ashley D; Harik V; Bicknell W
    Soc Sci Med; 1999 Oct; 49(7):905-20. PubMed ID: 10468395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationing of health care and the end-stage renal disease program.
    Klahr S
    Am J Kidney Dis; 1990 Oct; 16(4):392-5. PubMed ID: 2220792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh.
    Teerawattananon Y; Tantivess S; Yamabhai I; Tritasavit N; Walker DG; Cohen JT; Neumann PJ
    Health Res Policy Syst; 2016 Dec; 14(1):86. PubMed ID: 27912780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gaining efficiencies: resources and demand for dialysis around the globe.
    Neil N; Walker DR; Sesso R; Blackburn JC; Tschosik EA; Sciaraffia V; García-Contreras F; Capsa D; Bhattacharyya SK
    Value Health; 2009; 12(1):73-9. PubMed ID: 18680485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Policy and implementation of user fees in Jamaican public hospitals.
    Lewis MA; Parker C
    Health Policy; 1991 Jun; 18(1):57-85. PubMed ID: 10112302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The coming fiscal crisis: nephrology in the line of fire.
    Andersen MJ; Friedman AN
    Clin J Am Soc Nephrol; 2013 Jul; 8(7):1252-7. PubMed ID: 23704301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: access to ESRD treatments.
    Hörl WH; de Alvaro F; Williams PF
    Nephrol Dial Transplant; 1999; 14 Suppl 6():10-5. PubMed ID: 10528707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of end stage renal disease treatment.
    de Wit GA; Ramsteijn PG; de Charro FT
    Health Policy; 1998 Jun; 44(3):215-32. PubMed ID: 10182294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The economic burden of end-stage renal disease in Canada.
    Zelmer JL
    Kidney Int; 2007 Nov; 72(9):1122-9. PubMed ID: 17700643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards a higher priority for health on the development agenda.
    Yach D; von Schirnding YE
    Public Health Rev; 1994; 22(3-4):339-74. PubMed ID: 7708944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies.
    De Vecchi AF; Dratwa M; Wiedemann ME
    Nephrol Dial Transplant; 1999; 14 Suppl 6():31-41. PubMed ID: 10528710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Report from the Caribbean renal registry, 2006.
    Soyibo AK; Barton EN
    West Indian Med J; 2007 Sep; 56(4):355-63. PubMed ID: 18198742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of government and competing priorities in minority populations and developing nations.
    Depine S
    Ethn Dis; 2009; 19(1 Suppl 1):S1-73-9. PubMed ID: 19484881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of end-stage renal disease care in South Asia.
    Jha V
    Ethn Dis; 2009; 19(1 Suppl 1):S1-27-32. PubMed ID: 19484871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring the burden of illness for end-stage renal disease: some heavy lifting required.
    de Lissovoy G
    Kidney Int; 2007 Nov; 72(9):1045-7. PubMed ID: 17943151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic evaluation of policy options for dialysis in end-stage renal disease patients under the universal health coverage in Indonesia.
    Afiatin ; Khoe LC; Kristin E; Masytoh LS; Herlinawaty E; Werayingyong P; Nadjib M; Sastroasmoro S; Teerawattananon Y
    PLoS One; 2017; 12(5):e0177436. PubMed ID: 28545094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers to a functional renal transplant program in developing countries.
    Bamgboye EL
    Ethn Dis; 2009; 19(1 Suppl 1):S1-56-9. PubMed ID: 19484877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choosing between competing health priorities. A government payer perspective.
    Leese J
    Pharmacoeconomics; 1996; 9 Suppl 3():4-7; discussion 23-5. PubMed ID: 10160486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rationing in German health care with particular consideration of oncology: view points of German stakeholders--a qualitative interview study].
    Lange J; Gönner C; Vollmann J; Rauprich O
    Gesundheitswesen; 2015 Jan; 77(1):8-15. PubMed ID: 24696371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. End-stage renal disease in Indonesia: treatment development.
    Prodjosudjadi W; Suhardjono A
    Ethn Dis; 2009; 19(1 Suppl 1):S1-33-6. PubMed ID: 19484872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.